lactic acidosis

lactic acidosis is a serious metabolic condition characterized by an excessive accumulation of lactic acid in the bloodstream, leading to a significant decrease in blood pH. It is a form of metabolic acidosis and is typically defined by an arterial blood lactate level greater than 5 mmol/L and an arterial pH below 7.35. The condition arises from an imbalance between lactic acid production and clearance, often signaling underlying tissue hypoxia or systemic illness. Prompt recognition and treatment of the underlying cause are critical, as lactic acidosis is associated with high mortality, particularly in settings like intensive care units.

Definition and Overview

Lactic acidosis is formally classified as a high-anion gap metabolic acidosis resulting from the overproduction or underutilization of lactic acid. The Anion gap is calculated from standard electrolyte panels and is typically elevated in this condition. It is distinct from other acid-base disorders such as diabetic ketoacidosis or uremia. The condition can be further categorized using the Cohen-Woods classification system, which divides it into types related to inadequate oxygen delivery (Type A) and those unrelated to overt hypoxia (Type B). This framework is widely referenced in medical literature and guides clinical assessment. The Stewart approach to acid-base physiology provides another model for understanding the complex physicochemical determinants involved.

Causes and Pathophysiology

The primary causes of lactic acidosis are broadly divided into Type A, involving global or regional tissue hypoxia, and Type B, which occurs in the absence of hypoxia. Major Type A etiologies include states of shock (circulatory), such as cardiogenic shock, hypovolemic shock, and septic shock, as well as severe hypoxemia from conditions like acute respiratory distress syndrome. Type B causes are diverse and include systemic diseases like liver failure impairing lactate metabolism, ingestions of toxins like methanol or cyanide, and medications such as the biguanide metformin, particularly in the setting of renal impairment. Inborn errors of metabolism, like mitochondrial disorders or deficiencies in enzymes of the pyruvate dehydrogenase complex, are rare but important causes. The pathophysiology centers on a shift in cellular metabolism from aerobic respiration in the mitochondria to anaerobic glycolysis, leading to pyruvate being converted to lactate by the enzyme lactate dehydrogenase.

Signs and Symptoms

Clinical manifestations are often nonspecific and dominated by the underlying illness, but direct effects of acidosis may be present. Patients frequently exhibit signs of compensatory hyperventilation, known as Kussmaul respirations, as the body attempts to correct the acidemia. Cardiovascular signs include tachycardia and worsening hypotension due to decreased myocardial contractility and peripheral vasodilation. Neurological symptoms can range from lethargy and confusion to profound coma. Gastrointestinal symptoms like nausea, vomiting, and abdominal pain are common. In cases caused by tissue hypoxia, findings such as cool extremities, mottled skin, and oliguria may be prominent, reflecting poor perfusion.

Diagnosis

Diagnosis is confirmed through laboratory testing, primarily an arterial blood gas analysis revealing acidemia and a calculated elevated anion gap. A key diagnostic step is the direct measurement of serum lactate level, with modern point-of-care testing devices allowing rapid assessment in the emergency department. It is crucial to differentiate lactic acidosis from other high-anion gap acidoses like diabetic ketoacidosis (presence of ketones) or intoxication with salicylates. Further workup is directed at identifying the underlying cause and may include tests for sepsis (blood cultures), assessment of end-organ perfusion (central venous oxygen saturation), evaluation of renal function, and imaging studies such as computed tomography to locate ischemic tissue.

Treatment and Management

The cornerstone of treatment is the rapid identification and reversal of the underlying cause. For Type A lactic acidosis, this involves restoring adequate tissue oxygenation and perfusion through interventions like fluid resuscitation, administration of vasopressors (e.g., norepinephrine), and treatment of the source of sepsis. In specific poisonings, antidotes such as hydroxocobalamin for cyanide are used. The role of buffering agents like sodium bicarbonate is controversial and generally reserved for severe acidemia (pH <7.1) with hemodynamic instability. In refractory cases, renal replacement therapy (e.g., continuous venovenous hemofiltration) can help correct acidemia and remove lactate. Management of drug-induced cases, such as from metformin, requires immediate discontinuation of the offending agent and supportive care.

Prognosis and Complications

The prognosis is heavily dependent on the speed of correction of the inciting cause and the severity of the underlying disease. Lactic acidosis in the context of septic shock or cardiac arrest carries a very high mortality rate. Complications arise from both the profound acidosis and the hypoperfusion state, potentially leading to multiple organ dysfunction syndrome involving the kidneys (acute kidney injury), cardiovascular system (refractory shock), and central nervous system. Persistent acidosis impairs enzyme function and cellular processes across all organ systems. Survivors may have long-term morbidity related to the initial insult, such as cognitive impairment following prolonged cerebral hypoperfusion. Category:Medical conditions